About the MEU

A Leader in First-In-Patient Studies

The Medicines Evaluation Unit (MEU) Ltd is one of the UK’s leading contract research organisations, and a facility where commitment to excellence is paramount. Possessing extensive pharmaceutical, scientific and clinical expertise, allied with fast volunteer recruitment, both healthy and patient, within a state-of-the-art hospital based research facility, enables the MEU to offer clients positive clinical trial solutions.

The MEU’s bespoke database and trial management system I.C.A.R.U.S. assists recruitment of the right patient to the right study, facilitating rapid enrolment, allowing us to meet our clients’ timelines.

The MEU holds MHRA Phase I Accreditation, together with an MHRA Manufacturing Assembly Licence, enabling the company to perform assembly activities. We can also offer a full CRO service with our well-established partners.

Phase 1 Accreditation

The MEU is an MHRA Phase 1 accredited unit and has been part of the scheme since its inception. This ensures that our studies are conducted to the highest standards in terms of both safety and quality.

MHRA Phase I Accreditation:

  • Accredited since July 2009
  • Most recent inspection April 2015 (No Criticals, No Majors)

ISO 9001 Accreditation:

  • Accredited since August 2011
  • Last ISO audit October 2015

MIA IMP Licence:

  • Licensed since April 2008
  • Last inspection 16 Oct 2013 (No Criticals, No Majors)
  • Current licence v5 issued 04 Nov 2013
  • GMP Compliance Statement issued 21 Nov 2013

“Our mission is to help develop ground-breaking medicines for patients and future generations”

“Quality and safety are our fundamental principles”

“Our client-focused approach ensures we endeavour to always find positive solutions”